ClinicalTrials.gg
RecruitingNCT07485036MOMS-ADUpdated Oct 13, 2026

Maternal Outcomes: Mood, Alcohol Use, and Depressive Symptoms

An interventional study of Contingency Management & Problem Solving Therapy and Usual Care in Postpartum Depression (PPD), Alcohol Use and Contingency Management, sponsored by University of Illinois at Chicago. Recruiting at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-13.

Sponsored by University of Illinois at Chicago · Not applicable, Interventional, and Treatment

How we know

Updated Oct 13, 2026Now RecruitingSite recruiting status changed+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 220 studies in Depression, Postpartum with a site in United States — 38 open to participants now, 49 under way, 3 of them phase 3. Depression, Postpartum · United States.

Planned enrollment
154th of 198
30 · median 86
Started
2026
with 13 others
No phase
152 of 220
32 open now
Primary completion
2027-05
later than 19 of 48 live
Registered
208th of 220
by date

Among the 220 studies in Depression, Postpartum with a site in United States, this one is the 154th largest by planned enrollment of the 198 interventional ones that give a count, is one of 14 that started in 2026, is one of 152 with no phase, reaches primary completion later than 19 of the 48 other live ones, and was the 208th registered.

Depression, Postpartum

570 studies on the registry are indexed under Depression, Postpartum; 135 are open to participants now.

Browse Depression, Postpartum studies →

Open to participants now

38 of the 220 studies in Depression, Postpartum with a site in United States are open now. Recruiting first, the newest first:

32 more — sign in →

All 38 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 88 Depression, Postpartum studies recruiting now, 54 (61%) set no upper age limit and 31 (35%) stop at 75 or younger; 13 take children under 18; 40 take healthy volunteers.

This study: 18 Years and older · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 220 studies in Depression, Postpartum with a site in United States, or all of them as a file.
02

Study summary

This study aims to learn about depression and alcohol use in postpartum mothers and whether an intervention based on contingency management and problem-solving therapy (CM-PST) can help reduce these symptoms. The main questions it seeks to answer are:

  1. How do new mothers fare with depressive symptoms and alcohol use in the first 12 months after giving birth?
  2. Will a CM-PST intervention reduce depressive symptoms and alcohol use frequency among new mothers?
  3. Is a CM-PST intervention practical for new mothers?

The researchers will recruit approximately 30 new mothers and randomly select half to attend a 6-week CM-PST intervention. They will compare those who received the intervention versus those who did not to see if there are any differences in their depressive symptoms and alcohol usage.

Participants will:

  • Complete 4 remote intervention sessions over 6 weeks
  • Conduct at-home urine drug tests 2x per week during the 6-week intervention
  • Answer online surveys about their mental health and alcohol use
03

Conditions studied

  • Postpartum Depression (PPD)
  • Alcohol Use
  • Contingency Management
  • Problem Solving Therapy
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Biologically female
  • Age ≥18 years
  • Within 12 months postpartum
  • Able to provide

Exclusion criteria

Exclusion Criteria:

  • Serious medical or psychiatric conditions requiring hospitalization
  • Lifetime diagnosis of schizophrenia, bipolar disorder, or any psychiatric disorder
  • Current use of psychoactive drugs, medication to treat problematic alcohol use, or depression
  • Participation in past 6 months in problematic alcohol use or substance use treatment
  • Unable to provide consent
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Contingency Management & Problem Solving Therapy (CM-PST) Intervention Group

    Receives 4 remote sessions of CM-PST therapy over 6 weeks while conducting at home urine drug tests 2x weekly.

    Behavioral: Contingency Management & Problem Solving Therapy

  • Placebo comparator
    Usual Care Control Group

    Other: Usual Care

Interventions

  • BehavioralContingency Management & Problem Solving Therapy

    A 6-week online CM-PST course delivered through video conferencing calls consisting of 4 educational sessions, combined with 2x weekly at-home drug testing to monitor the reduction in alcohol use and reduced depression symptoms.

  • OtherUsual Care

    Participants randomized to the usual care condition will continue to receive standard postpartum care from their obstetrician-gynecologist, consistent with routine clinical practice. No additional psychological intervention will be provided as part of the study.

06

What researchers measure

Primary outcomes

  1. Change in postpartum depression symptoms

    Participants will take the Edinburgh Postnatal Depression Scale (EPDS) at screening, baseline and at 3 months to assess changes in mental health and depressive symptoms. This is reported on a scale of 0-30; a higher score indicates a higher likelihood of postpartum depression.

    Time frame: Screening, Baseline, 3 months

  2. Alcohol use test results

    Participants' alcohol use will be monitored and assessed with urine drug tests at baseline, 2x weekly throughout the duration of the 6-week intervention, and at 3 months.

    Time frame: Baseline, Weekly, 3 months

  3. Change in alcohol use screening status

    Participants will take the Alcohol Use Disorders Identification Test (AUDIT) at the time of screening, baseline and at 3 months. This is reported on a scale of 0-40; a higher score indicates a higher likelihood of moderate to severe alcohol use.

    Time frame: Screening, Baseline, 3 months

  4. Change in alcohol-related negative consequences

    Participants will take the Rutgers Alcohol Problems Index (RAPI) at baseline and at 3 months to assess changes in problems related to alcohol use. This is reported on a scale of 0-72; a higher score indicates a higher likelihood of alcohol-related negative consequences in everyday life.

    Time frame: Baseline, 3 months

  5. Change in alcohol use

    Participants will take the Timeline Follow Back (TLFB) questionnaire at baseline and at 3 months to assess changes in alcohol use.

    Time frame: Baseline, 3 months

  6. Change in reasons for drinking

    Participants will take the Drinking Motive Questionnaire-Revised (DMQ-R) at baseline and at 3 months to assess changes in alcohol use motivations. This is reported on a scale of 20-100; a higher score indicates stronger motivations for alcohol use.

    Time frame: Baseline, 3 months

Secondary outcomes

  1. Acceptability of intervention

    Participants will complete a 10-minute interview at the end of the intervention to assess their sentiments towards CM-PST and take the Client Counseling Satisfaction Scale (CCSS). This is reported on a five-point Likert scale of 6-30, and includes an open-ended question about suggestions for future interventions. A higher score indicates a higher likelihood of participant satisfaction.

    Time frame: 3 months

  2. Feasibility of intervention via adherence

    Participant adherence will be assessed by monitoring and documenting attendance for each intervention session and completion of urine alcohol screening tests.

    Time frame: 3 months

  3. Feasibility of intervention via retention

    Participant retention will be assessed by monitoring and calculating the proportion of the study sample retained by the end of the intervention.

    Time frame: 3 months

07

Study locations

1 of 1 sites recruiting
  • University of Illinois Hospital and Health Sciences System, University of Illinois College of Medicine
    Chicago, Illinois 60612, United States
    Recruiting
    • Hagar Hallihan, PhD, RN · Contacthhalli2@uic.edu · 312-413-7822
    • Hagar Hallihan, PhD · Principal investigator
08

References and documents

Individual participant data

Plan to share: Yes — We will adhere to the NIH Grant Policy on Sharing of Unique Research Resources including the Principles and Guidelines for Recipients of NIH Research Grants and Contracts on Obtaining and Disseminating Biomedical Research Resources issued December 23, 1999. Data from this research will be shared and the results of this research will be made available via publication in scientific journals and through scientific meetings where our findings are reported. Publication of data shall occur during the project, if appropriate, or at the end of the project, consistent with typical scientific practices. All publications will be made publicly available consistent with NIH policies.

Supporting information: Statistical analysis plan, Clinical study report

Time frame: After analyzing data.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for May 2027, 7 months later.

Of 259 non-industry interventional studies with no phase under Depression, Postpartum, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 35. This study's planned 7 months is below that.

Counting every sponsor, half of 265 studies reached it within 23 months; a quarter within 11 and three quarters within 35.

Start moved once since we started tracking on Sep 25, 2026: Jun 2026 → Oct 2026, on Oct 13, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Feb 18, 2026
First posted
Mar 20, 2026
StartEst.
Oct 1, 2026was Jun 2026
Primary completionEst.
May 30, 2027
CompletionEst.
Nov 30, 2027
Last update
Oct 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Oct 13, 2026
Sites
University of Illinois Hospital and Health Sciences System, University of Illinois College of Medicine is now Recruiting
Oct 13, 2026
Start date
Jun 1, 2026→Oct 1, 2026
Oct 13, 2026
Contact
Study contact's phone or email changed: •••5361→•••7822. See the current contact
Oct 13, 2026
Site contacts
Changed at 1 site. See the sites
Show the site
  • University of Illinois Hospital and Health Sciences System, University of Illinois College of Medicine · Chicago, United StatesContact •••5361→•••7822
Oct 13, 2026
Show all 1 update
  1. Oct 13, 2026
    Not yet recruiting→Recruiting
    University of Illinois Hospital and Health Sciences System, University of Illinois College of Medicine is now Recruiting
    Start date Jun 1, 2026→Oct 1, 2026
    Contact Study contact's phone or email changed: •••5361→•••7822. See the current contact
    Site contacts Changed at 1 site. See the sites
    Show the site
    • University of Illinois Hospital and Health Sciences System, University of Illinois College of Medicine · Chicago, United StatesContact •••5361→•••7822
    + 1 other change: oversight details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07485036
Responsible party
Sponsor
First posted
Mar 20, 2026
Start date
Oct 1, 2026 (estimated)
Primary completion
May 30, 2027 (estimated)
Completion
Nov 30, 2027 (estimated)
Last update
Oct 13, 2026

Study contacts

Hagar Hallihan, PhD, RN
Contact
hhalli2@uic.edu
312-413-7822

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion